Lipidomics studies on macrophages - bone marrow-derived macrophages treated with 25-hydroxy-cholesterol +/- lipid-depleted media containing compactin
Introduction | Browse | DownloadMouse-over the above links for more information
Treatment details
| LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
|---|---|---|---|---|---|---|
| - | PE(36:5e)/PE(36:4p) | KDO | 0.0 | BCG061213A03 | 162 | pmol/1E6 cells |
| - | PE(36:5e)/PE(36:4p) | KDO | 0.0 | BCG061213C03 | 134 | pmol/1E6 cells |
| - | PE(36:5e)/PE(36:4p) | KDO | 0.0 | BCG061213B03 | 166 | pmol/1E6 cells |
| - | PE(36:5e)/PE(36:4p) | KDO | 6.0 | BCG061213B02 | 249 | pmol/1E6 cells |
| - | PE(36:5e)/PE(36:4p) | KDO | 6.0 | BCG061213C02 | 286 | pmol/1E6 cells |
| - | PE(36:5e)/PE(36:4p) | KDO | 6.0 | BCG061213A02 | 251 | pmol/1E6 cells |
| - | PE(36:5e)/PE(36:4p) | KDO | 24.0 | BCG061213C01 | 105 | pmol/1E6 cells |
| - | PE(36:5e)/PE(36:4p) | KDO | 24.0 | BCG061213A01 | 78.2 | pmol/1E6 cells |
| - | PE(36:5e)/PE(36:4p) | KDO | 24.0 | BCG061213B01 | 101 | pmol/1E6 cells |